D-0520-2026 Class II Ongoing

Recalled by JB Chemicals And Pharmaceuticals Ltd — Mumbai

FDA drug recall D-0520-2026 was initiated by JB Chemicals And Pharmaceuticals Ltd on Apr 23, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test The recall status is ongoing. Affected quantity: 675 bottles.

Recall details

Product Type
Drugs
Report Date
May 13, 2026
Initiation Date
Apr 23, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
675 bottles

Product description

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.

Reason for recall

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Distribution pattern

Nationwide in the USA

Code information

Lot #: GEH25023, Expires: 6/30/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0520-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0520-2026. Report a data issue: hello@regdatalab.com.